These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3143042)
41. Antigenic and immunogenic properties of cyanogen bromide peptides from a serotype 5 gonococcal outer membrane protein I. Teerlink T; Versantvoort H; Beuvery EC Antonie Van Leeuwenhoek; 1987; 53(6):493-9. PubMed ID: 2453158 [TBL] [Abstract][Full Text] [Related]
42. Neisserial surface variation: how and why? Swanson J; Belland RJ; Hill SA Curr Opin Genet Dev; 1992 Oct; 2(5):805-11. PubMed ID: 1360853 [TBL] [Abstract][Full Text] [Related]
43. Development of a gonorrhoea vaccine: prospects, strategies and tactics. Gotschlich EC Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769 [TBL] [Abstract][Full Text] [Related]
44. Loss of both Holliday junction processing pathways is synthetically lethal in the presence of gonococcal pilin antigenic variation. Sechman EV; Kline KA; Seifert HS Mol Microbiol; 2006 Jul; 61(1):185-93. PubMed ID: 16824104 [TBL] [Abstract][Full Text] [Related]
45. Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis. Virji M; Heckels JE J Gen Microbiol; 1989 Jul; 135(7):1895-9. PubMed ID: 2482335 [TBL] [Abstract][Full Text] [Related]
46. The interaction of naturally elaborated blebs from serum-susceptible and serum-resistant strains of Neisseria gonorrhoeae with normal human serum. Pettit RK; Judd RC Mol Microbiol; 1992 Mar; 6(6):729-34. PubMed ID: 1574002 [TBL] [Abstract][Full Text] [Related]
47. Expression of a cloned lipopolysaccharide antigen from Neisseria gonorrhoeae on the surface of Escherichia coli K-12. Palermo DA; Evans TM; Clark VL Infect Immun; 1987 Nov; 55(11):2844-9. PubMed ID: 3117695 [TBL] [Abstract][Full Text] [Related]
54. Production of Neisseria gonorrhoeae pili (fimbriae) in Pseudomonas aeruginosa. Hoyne PA; Haas R; Meyer TF; Davies JK; Elleman TC J Bacteriol; 1992 Nov; 174(22):7321-7. PubMed ID: 1358873 [TBL] [Abstract][Full Text] [Related]
55. Pilin gene variation in Neisseria gonorrhoeae: reassessing the old paradigms. Hill SA; Davies JK FEMS Microbiol Rev; 2009 May; 33(3):521-30. PubMed ID: 19396954 [TBL] [Abstract][Full Text] [Related]
56. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Stern A; Brown M; Nickel P; Meyer TF Cell; 1986 Oct; 47(1):61-71. PubMed ID: 3093085 [TBL] [Abstract][Full Text] [Related]
57. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies. Wetzler LM; Blake MS; Gotschlich EC Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644 [No Abstract] [Full Text] [Related]
59. Sequence changes in the pilus subunit lead to tropism variation of Neisseria gonorrhoeae to human tissue. Jonsson AB; Ilver D; Falk P; Pepose J; Normark S Mol Microbiol; 1994 Aug; 13(3):403-16. PubMed ID: 7997158 [TBL] [Abstract][Full Text] [Related]
60. Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies. Wang S; Xue J; Lu P; Ni C; Cheng H; Han R; van der Veen S J Infect; 2018 Sep; 77(3):191-204. PubMed ID: 29902495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]